BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29622904)

  • 1. Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia.
    Zawdie B; Tadesse S; Wolide AD; Nigatu TA; Bobasa EM
    Ethiop J Health Sci; 2018 Jan; 28(1):19-30. PubMed ID: 29622904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.
    Ciardullo S; Muraca E; Perra S; Bianconi E; Zerbini F; Oltolini A; Cannistraci R; Parmeggiani P; Manzoni G; Gastaldelli A; Lattuada G; Perseghin G
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32049637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of serum ferritin and De Ritis ratio in non-alcoholic fatty liver disease as diagnostic markers.
    Javed A; Mehboob K; Rashid A; Majeed A; Ibrahim MI; Mushtaq I
    J Pak Med Assoc; 2024 Apr; 74(4):656-660. PubMed ID: 38751257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of persistently elevated liver enzymes in type 2 diabetic outpatients.
    Giandalia A; Romeo EL; Ruffo MC; Muscianisi M; Giorgianni L; Forte F; Cucinotta D; Russo GT
    Prim Care Diabetes; 2017 Jun; 11(3):226-232. PubMed ID: 28017576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
    Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
    Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes.
    Afarideh M; Aryan Z; Ghajar A; Ganji M; Ghaemi F; Saadat M; Heidari B; Mechanick JI; Esteghamati A
    Prim Care Diabetes; 2019 Dec; 13(6):505-514. PubMed ID: 31054837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD).
    Darmadi D; Ruslie RH
    Rom J Intern Med; 2021 Mar; 59(1):66-72. PubMed ID: 33055315
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study.
    Deravi N; Dehghani Firouzabadi F; Moosaie F; Asadigandomani H; Arab Bafrani M; Yoosefi N; Poopak A; Dehghani Firouzabadi M; Poudineh M; Rabizadeh S; Kamel I; Nakhjavani M; Esteghamati A
    Front Endocrinol (Lausanne); 2023; 14():1147458. PubMed ID: 37342261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
    Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
    Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
    Tian F; Zheng Z; Zhang D; He S; Shen J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30473540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
    Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
    J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.
    Lin MS; Lin HS; Chung CM; Lin YS; Chen MY; Chen PH; Hu JH; Chou WN; Huang JC; Huang TJ
    BMJ Open; 2015 Sep; 5(9):e008797. PubMed ID: 26369802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
    Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.